Primary care engagement in hidradenitis suppurativa: Influence of disease severity, cardiometabolic risk, and access barriers.
C, M., SB, R., M, A., L, T., & T, M. (2026). Primary care engagement in hidradenitis suppurativa: Influence of disease severity, cardiometabolic risk, and access barriers.. Dermatology online journal. https://doi.org/10.25251/jc8msv36
C M, SB R, M A, L T, T M. Primary care engagement in hidradenitis suppurativa: Influence of disease severity, cardiometabolic risk, and access barriers.. Dermatology online journal. 2026; doi: 10.25251/jc8msv36
C M, SB R, M A, et al. Primary care engagement in hidradenitis suppurativa: Influence of disease severity, cardiometabolic risk, and access barriers.[J]. Dermatology online journal. 2026. DOI: 10.25251/jc8msv36.
@article{c2026,
author = {McRae C and Reddy SB and Anderson M and Turner L and Mayo T},
title = {Primary care engagement in hidradenitis suppurativa: Influence of disease severity, cardiometabolic risk, and access barriers.},
journal = {Dermatology online journal},
year = {2026},
doi = {10.25251/jc8msv36},
note = {PMID: 42522477},
}
TY - JOUR AU - McRae C AU - Reddy SB AU - Anderson M AU - Turner L AU - Mayo T TI - Primary care engagement in hidradenitis suppurativa: Influence of disease severity, cardiometabolic risk, and access barriers. T2 - Dermatology online journal PY - 2026 DO - 10.25251/jc8msv36 AN - PMID:42522477 ER -
BACKGROUND: Hidradenitis suppurativa (HS) is linked to cardiometabolic disease (CMD), and guidelines recommend annual primary care visits. This study examined predictors of primary care utilization among patients with HS. METHODS: In this cross-sectional study, 307 patients with HS were analyzed. χ2 tests, one-way analysis of variance, and multivariable logistic regression assessed associations among barriers to care, primary care provider (PCP) adherence, HS severity, and CMD presence. RESULTS: Mean age was 39.4 years; 26.4% had Hurley stage III disease. Overall PCP adherence was 85.0% but lower in patients under 30 years (71.0%). CMD prevalence included hypertension (33.9%), type 2 diabetes (17.6%), and hypercholesterolemia (32.9%). Patients without CMD were 74.0% less likely to adhere to annual PCP visits (adjusted odds ratio [AOR], 0.26; P = .001), and being uninsured reduced adherence by 82.0% (AOR, 0.18; P = .01). HS severity did not predict adherence, but Hurley stage III disease was associated with more PCP visits and independently predicted type 2 diabetes (AOR, 2.26; P = .02). CONCLUSION: Primary care engagement is influenced more by CMD and insurance than HS severity. Coordinated dermatology-primary care strategies may enhance preventive care, especially for younger patients without CMD.